Longevity Health director Kathryn Gregory resigns
Longevity Health Holdings, Inc. reported a change in its Board of Directors.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Longevity Health Holdings, Inc. reported a change in its Board of Directors. On June 1, 2026, Kathryn Gregory notified the company that she was resigning from the Board, effective at the close of business that same day. The company states that her resignation was not due to any disagreement regarding its operations, policies, or practices, indicating a routine governance change rather than a dispute-driven departure.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Resignation effective date: June 1, 2026
1 metrics
Resignation effective date
June 1, 2026
Effective at close of business
Key Terms
Item 5.02, Emerging growth company, Board of Directors, Chief Financial Officer
4 terms
Item 5.02 regulatory
"Item 5.02. Departure of Directors or Certain Officers; Election of Directors"
Item 5.02 is a specific disclosure category on the U.S. Securities and Exchange Commission’s Form 8‑K that requires public companies to report changes in key personnel and related compensation arrangements. It covers departures and appointments of directors and certain officers, elections of directors, and new or material changes to compensatory agreements for those persons; the company must file a Form 8‑K with the required information and any related exhibits within the SEC’s prescribed reporting timeframe. The item is a rule‑based reporting obligation under U.S. securities law, so its scope and timing follow the SEC’s definitions and deadlines rather than informal usage.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Board of Directors financial
"resignation from the Board of Directors of the Company"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Chief Financial Officer financial
"Bryan J. Cassaday | | | | Chief Financial Officer"
A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What board change did Longevity Health Holdings (XAGE) disclose in this 8-K?
Longevity Health Holdings disclosed that director Kathryn Gregory resigned from its Board, effective at the close of business on June 1, 2026. The company indicated her resignation was not due to any disagreement over operations, policies, or practices.
When did Kathryn Gregory’s resignation from Longevity Health Holdings (XAGE) become effective?
Her resignation became effective at the close of business on June 1, 2026. This means she ceased serving as a director at the end of that business day, following notice provided to Longevity Health Holdings on the same date.
Did Kathryn Gregory resign from Longevity Health Holdings (XAGE) due to a disagreement?
No, the company states that Kathryn Gregory’s resignation was not the result of any disagreement with Longevity Health Holdings. This covers matters related to its operations, policies, or practices, suggesting a non-contentious transition.
Which SEC item does the Longevity Health Holdings (XAGE) filing relate to?
The filing relates to Item 5.02, which covers departures and appointments of directors or certain officers and compensatory arrangements. Here, it specifically reports the resignation of director Kathryn Gregory from the Board of Longevity Health Holdings.
Who signed the Longevity Health Holdings (XAGE) 8-K reporting the director resignation?
The 8-K was signed on behalf of Longevity Health Holdings by Bryan J. Cassaday, who serves as the company’s Chief Financial Officer. His signature indicates the company’s authorization and responsibility for the disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
